Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Early Hum Dev. 2018 Mar 23;119:68–72. doi: 10.1016/j.earlhumdev.2018.02.010

Table 2.

Clinical and perinatal characteristics of the infants who followed up for BSID-III test and those who lost to follow up.

Variable Follow up (N = 44) Lost to follow up (N = 16) p-Value
Birth weight in grams (mean ± sd) 856 ( ± 280) 900 ( ± 237) 0.5
Gestational age (mean ± sd) 26 ( ± 2) 26 ( ± 2) 0.8
PMA at study (mean ± sd) 39 ( ± 2) 38.5 ( ± 2) 0.4
CRIB-II score (mean ± sd) 11 ( ± 3) 11 ( ± 3) 0.8
NEC surgery, n (%) 7 (15.9%) 3 (18.8%) 0.7
PDA ligation, n (%) 6 (13.6%) 2 (12.5%) 0.9
ROP surgery, n (%) 13 (29.5%) 3 (18.8%) 0.5
Post-natal steroids, n (%) 15 (34.1%) 2 (12.5%) 0.1
Oxygen therapy at 36 wk., n (%) 34 (77.3%) 14 (87.5%) 0.5
Inotropes, n (%) 21 (47.7%) 8 (50%) 0.2
IVH grade 3–4, n (%) 19 (43.2%) 7 (43.8%) 0.9
Moderate/severe injury on MRI at TEA, n (%) 25 (56.8%) 7 (43.8%) 0.4